Behcet’s Disease (BD) is a chronic inflammatory
multisystem disease belongs to the Vasculitidies with small,
medium and large sized vessel involvement. This disorder is
characterized by Oral aphthosis, Genital aphthosis, ocular
inflammation, skin lesions, vascular involvement, positive Pathergy
test and HLA-B51 positivity.
When a patient is involved in Behcet’s Disease (BD) but
his/her disease is presented as simple oral aphthosis and in which
the pathergy test and/or HLA-B51 are positive but other clinical
features are obscured; it is called subclinical BD.
Two types of subclinical BD have been detected by the author yet;
type I and type II.
Subclinical BD type I is a varient of BD with the combination of:
• Low frequent, minor, recurrent oral aphthosis
• Occasionally a few pseudofolliculitis lesions and
• The pathergy test and/or HLA-B51 positivity
Subclinical BD type II is a varient of BD with the combination of:
• Low frequent, minor, recurrent oral aphthosis
• Recurrent internal genital (vaginal/cervical) aphthosis and
• The pathergy test and/or HLA-B51 positivity
Indeed some parts of the cases with simple oral aphthosis
are the cases with missed subclinical BD.
So, the author thinks that, the prevalence of BD may be
underestimated.
Keywords: Oral Aphthosis; Genital Aphthosis; HLA-B51
Positivity; Pathergy Test; Subclinical BD Type I and II
Open Access
Peer Reviewed
ISSN: 2378-6337
Autoimmune Diseases and Therapeutic Approaches
International open-access publishing for high-quality research, reviews, case studies, and scholarly communication.
Submit Manuscript
Original Research
Article in Press
Subclinical Behcet’s Disease
Iraj Salehi-Abari
Corresponding Author: Iraj Salehi-Abari
Received: Sep 30, 2016
Accepted: Oct 07, 2016
Published: Oct 10, 2016
Views: 4
DOI: N/A
Abstract
Iraj Salehi-Abari (2016), Subclinical Behcet’s Disease. Autoimmune Dis Ther Approaches 3:124
Copyright:
Copyright: © 2016 ADTAOA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, Version 3.0, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Indexed In
Google Scholar
DOAJ
PubMed
Scopus